CZ20031502A3 - Ortho- a meta-substituované bisarylové sloučeniny a farmaceutické prostředky, které je obsahují - Google Patents

Ortho- a meta-substituované bisarylové sloučeniny a farmaceutické prostředky, které je obsahují

Info

Publication number: CZ20031502A3
Authority: CZ; Czechia
Prior art keywords: ortho; meta; comprised; pharmaceutical preparations; bisaryl compounds
Prior art date: 2000-11-30

Application number

CZ20031502A

Other languages

English (en)

Other versions

CZ301631B6 (cs

Inventor

Stefan Peukert

Joachim Brendel

Horst Hemmerle

Heinz-Werner Kleemann

Original Assignee

Aventis Pharma Deutschland Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-30

Filing date

2001-11-17

Publication date

2003-08-13

2001-11-17 Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh

2003-08-13 Publication of CZ20031502A3 publication Critical patent/CZ20031502A3/cs

2010-05-05 Publication of CZ301631B6 publication Critical patent/CZ301631B6/cs

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

CZ20031502A 2000-11-30 2001-11-17 Ortho- a meta-substituované bisarylové slouceniny a farmaceutické prostredky, které je obsahují CZ301631B6 (cs)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10059418A DE10059418A1 (de)	2000-11-30	2000-11-30	Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Publications (2)

Publication Number	Publication Date
CZ20031502A3 true CZ20031502A3 (cs)	2003-08-13
CZ301631B6 CZ301631B6 (cs)	2010-05-05

Family

ID=7665215

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CZ20031502A CZ301631B6 (cs)	2000-11-30	2001-11-17	Ortho- a meta-substituované bisarylové slouceniny a farmaceutické prostredky, které je obsahují

Country Status (29)

Country	Link
US (2)	US6605625B2 (cs)
EP (1)	EP1339675B1 (cs)
JP (1)	JP4051283B2 (cs)
KR (1)	KR100968056B1 (cs)
CN (1)	CN1290825C (cs)
AR (1)	AR031430A1 (cs)
AT (1)	ATE289292T1 (cs)
AU (2)	AU2002227931B2 (cs)
BR (1)	BR0115769A (cs)
CA (1)	CA2430273C (cs)
CZ (1)	CZ301631B6 (cs)
DE (2)	DE10059418A1 (cs)
EE (1)	EE05240B1 (cs)
ES (1)	ES2236341T3 (cs)
HK (1)	HK1061231A1 (cs)
HR (1)	HRP20030436B1 (cs)
HU (1)	HUP0303317A3 (cs)
IL (2)	IL156097A0 (cs)
MX (1)	MXPA03004386A (cs)
NO (1)	NO328599B1 (cs)
NZ (1)	NZ526177A (cs)
PL (1)	PL206245B1 (cs)
PT (1)	PT1339675E (cs)
RS (1)	RS50403B (cs)
RU (1)	RU2278858C2 (cs)
SK (1)	SK286708B6 (cs)
TW (1)	TWI254039B (cs)
WO (1)	WO2002044137A1 (cs)
ZA (1)	ZA200303893B (cs)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10060807A1 (de) *	2000-12-07	2002-06-20	Aventis Pharma Gmbh	Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
GB0124933D0 (en) *	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124931D0 (en) *	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124938D0 (en) *	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124939D0 (en) *	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124941D0 (en) *	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124936D0 (en) *	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124934D0 (en) *	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
CN100369898C (zh) *	2002-02-12	2008-02-20	史密丝克莱恩比彻姆公司	用作p38抑制剂的烟酰胺衍生物
GB0217757D0 (en)	2002-07-31	2002-09-11	Glaxo Group Ltd	Novel compounds
EP1546128B1 (en)	2002-08-19	2006-05-03	Glaxo Group Limited	Pyrimidine derivatives as selective cox-2 inhibitors
GB0221443D0 (en)	2002-09-16	2002-10-23	Glaxo Group Ltd	Pyridine derivates
AU2003291839B2 (en) *	2002-12-13	2009-01-22	Ym Biosciences Australia Pty Ltd	Nicotinamide-based kinase inhibitors
SI1569907T1 (sl) *	2002-12-13	2016-06-30	Ym Biosciences Australia Pty Ltd	Na nikotinamidu osnovani kinazni inhibitorji
EP1569907B1 (en) *	2002-12-13	2016-03-09	YM BioSciences Australia Pty Ltd	Nicotinamide-based kinase inhibitors
GB0308185D0 (en) *	2003-04-09	2003-05-14	Smithkline Beecham Corp	Novel compounds
GB0315950D0 (en)	2003-06-11	2003-08-13	Xention Discovery Ltd	Compounds
DE10341233A1 (de) *	2003-09-08	2005-03-24	Aventis Pharma Deutschland Gmbh	Kombination von Phenylcarbonsäureamiden mit beta-Adrenozeptoren-Blockern und deren Verwendung zur Behandlung von Vorhofarrhythmien
US20050054673A1 (en) *	2003-09-08	2005-03-10	Aventis Pharma Deutschland Gmbh	Combination of phenylcarboxylic acid amides with beta-adrenoreceptor blockers and their use for the treatment of atrial arrhythmias
JP4794446B2 (ja) *	2003-09-23	2011-10-19	メルク・シャープ・エンド・ドーム・コーポレイション	イソキノリン系カリウムチャンネル阻害薬
US7647300B2 (en) *	2004-01-26	2010-01-12	Google Inc.	Methods and systems for output of search results
GB0402143D0 (en) *	2004-01-30	2004-03-03	Smithkline Beecham Corp	Novel compounds
GB0403744D0 (en) *	2004-02-20	2004-03-24	Astrazeneca Ab	Chemical process
JP2007528420A (ja) *	2004-03-11	2007-10-11	グラクソ　グループ　リミテッド	新規ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
GB0412986D0 (en)	2004-06-10	2004-07-14	Xention Discovery Ltd	Compounds
US7569589B2 (en)	2004-07-29	2009-08-04	Merck & Co., Inc.	Potassium channel inhibitors
CN1993348A (zh) *	2004-07-29	2007-07-04	默克公司	钾通道抑制剂
US20080051416A1 (en) *	2004-10-05	2008-02-28	Smithkline Beecham Corporation	Novel Compounds
WO2006055553A2 (en)	2004-11-15	2006-05-26	Glaxo Group Limited	Novel m3 muscarinic acetylcholine receptor antagonists
US7576212B2 (en)	2004-12-09	2009-08-18	Xention Limited	Thieno[2,3-B] pyridines as potassium channel inhibitors
GB0512429D0 (en) *	2005-06-17	2005-07-27	Smithkline Beecham Corp	Novel compound
WO2007015775A2 (en) *	2005-07-22	2007-02-08	Merck & Co., Inc.	Potassium channel inhibitors
GB0525164D0 (en)	2005-12-09	2006-01-18	Xention Discovery Ltd	Compounds
EP2012758A2 (en) *	2006-04-27	2009-01-14	Sanofi-Aventis Deutschland GmbH	Inhibitors of the task-1 and task-3 ion channel
CL2008000066A1 (es)	2007-01-12	2008-08-01	Smithkline Beecham Corp	Compuestos derivados de (5-hidroxi-3-oxo-2,3-dihidropiridazina-4-carbonil)glicina, inhibidores de hif prolil hidroxilasas; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la anem
JP5735799B2 (ja)	2007-04-06	2015-06-17	ニューロクラインバイオサイエンシーズ，インコーポレイテッド	ゴナドトロピン放出ホルモン受容体拮抗薬およびそれに関連する方法
PE20090236A1 (es) *	2007-04-06	2009-03-13	Neurocrine Biosciences Inc	Antagonistas de los receptores de la hormona liberadora de gonadotropina y procedimientos relacionados con ellos
GB0815782D0 (en)	2008-08-29	2008-10-08	Xention Ltd	Novel potassium channel blockers
GB0815784D0 (en)	2008-08-29	2008-10-08	Xention Ltd	Novel potassium channel blockers
GB0815781D0 (en)	2008-08-29	2008-10-08	Xention Ltd	Novel potassium channel blockers
GB201105659D0 (en)	2011-04-01	2011-05-18	Xention Ltd	Compounds
NO3175985T3 (cs)	2011-07-01	2018-04-28
US20150045305A1 (en)	2012-01-27	2015-02-12	Gilead Sciences, Inc.	Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
TWI773657B (zh)	2015-12-18	2022-08-11	美商亞德利克斯公司	作爲非全身ｔｇｒ５促效劑之經取代之4-苯基吡啶化合物
US12084472B2 (en)	2015-12-18	2024-09-10	Ardelyx, Inc.	Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
CN107573292B (zh) *	2017-09-04	2022-06-24	江苏艾立康医药科技有限公司	作用于脯氨酰羟化酶的吡嗪衍生化合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE59107440D1 (de) *	1990-02-19	1996-04-04	Ciba Geigy Ag	Acylverbindungen
GB9220137D0 (en) *	1992-09-23	1992-11-04	Pfizer Ltd	Therapeutic agents
HUT73813A (en) *	1993-06-30	1996-09-30	Wellcome Found	Anti-athero-sclerotic diaryl compounds, process to prepare them and pharmaceutical compositions contg. them
GB9416972D0 (en) *	1994-08-23	1994-10-12	Smithkline Beecham Plc	Carbon side chain/indole/indolene
DE4430638A1 (de)	1994-08-29	1996-03-07	Bayer Ag	Verwendung von substituierten 4-Phenyl-6-amino-nicotinsäurederivaten als Arzneimittel
DE4432101A1 (de) *	1994-09-09	1996-03-14	Hoechst Ag	Aminosäure-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US5670504A (en)	1995-02-23	1997-09-23	Merck & Co. Inc.	2,6-diaryl pyridazinones with immunosuppressant activity
US6083986A (en) *	1996-07-26	2000-07-04	Icagen, Inc.	Potassium channel inhibitors
US5969017A (en)	1996-10-31	1999-10-19	Merck & Co., Inc.	Methods of treating or preventing cardiac arrhythmia
US5935945A (en)	1996-10-31	1999-08-10	Merck & Co., Inc.	Methods of treating or preventing cardiac arrhythmia
KR100241350B1 (ko) *	1997-10-27	2000-02-01	정선종	전자 거래에서 안전한 전자 공증문서 생성방법
US6333337B1 (en) *	1998-01-27	2001-12-25	Icagen, Inc.	Potassium channel inhibitors
CA2341678C (en) *	1998-09-01	2009-10-13	Bristol-Myers Squibb Company	Potassium channel inhibitors and method
EP1113000A4 (en) *	1998-09-11	2004-12-15	Ajinomoto Kk	BENZENE DERIVATIVES AND THEIR MEDICAL APPLICATION
DE19947457A1 (de) *	1999-10-02	2001-04-05	Aventis Pharma Gmbh	2'-Substituierte 1,1'-Biphenyl-2-carbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen

2000
- 2000-11-30 DE DE10059418A patent/DE10059418A1/de not_active Withdrawn
2001
- 2001-11-17 BR BR0115769-8A patent/BR0115769A/pt not_active Application Discontinuation
- 2001-11-17 AU AU2002227931A patent/AU2002227931B2/en not_active Ceased
- 2001-11-17 RS YUP-376/03A patent/RS50403B/sr unknown
- 2001-11-17 ES ES01989479T patent/ES2236341T3/es not_active Expired - Lifetime
- 2001-11-17 CA CA2430273A patent/CA2430273C/en not_active Expired - Fee Related
- 2001-11-17 HU HU0303317A patent/HUP0303317A3/hu unknown
- 2001-11-17 SK SK653-2003A patent/SK286708B6/sk not_active IP Right Cessation
- 2001-11-17 IL IL15609701A patent/IL156097A0/xx unknown
- 2001-11-17 DE DE50105386T patent/DE50105386D1/de not_active Expired - Lifetime
- 2001-11-17 PT PT01989479T patent/PT1339675E/pt unknown
- 2001-11-17 JP JP2002546507A patent/JP4051283B2/ja not_active Expired - Fee Related
- 2001-11-17 AT AT01989479T patent/ATE289292T1/de active
- 2001-11-17 RU RU2003119153/04A patent/RU2278858C2/ru not_active IP Right Cessation
- 2001-11-17 NZ NZ526177A patent/NZ526177A/en unknown
- 2001-11-17 CN CNB01819740XA patent/CN1290825C/zh not_active Expired - Fee Related
- 2001-11-17 AU AU2793102A patent/AU2793102A/xx active Pending
- 2001-11-17 PL PL362700A patent/PL206245B1/pl not_active IP Right Cessation
- 2001-11-17 MX MXPA03004386A patent/MXPA03004386A/es active IP Right Grant
- 2001-11-17 CZ CZ20031502A patent/CZ301631B6/cs not_active IP Right Cessation
- 2001-11-17 WO PCT/EP2001/013294 patent/WO2002044137A1/de active IP Right Grant
- 2001-11-17 KR KR1020037007255A patent/KR100968056B1/ko not_active IP Right Cessation
- 2001-11-17 EE EEP200300183A patent/EE05240B1/xx not_active IP Right Cessation
- 2001-11-17 EP EP01989479A patent/EP1339675B1/de not_active Expired - Lifetime
- 2001-11-28 AR ARP010105540A patent/AR031430A1/es unknown
- 2001-11-28 TW TW090129358A patent/TWI254039B/zh not_active IP Right Cessation
- 2001-11-29 US US09/995,771 patent/US6605625B2/en not_active Expired - Fee Related
2003
- 2003-05-20 ZA ZA200303893A patent/ZA200303893B/en unknown
- 2003-05-25 IL IL156097A patent/IL156097A/en not_active IP Right Cessation
- 2003-05-28 NO NO20032438A patent/NO328599B1/no not_active IP Right Cessation
- 2003-05-29 HR HR20030436A patent/HRP20030436B1/xx not_active IP Right Cessation
- 2003-06-04 US US10/453,646 patent/US6924392B2/en not_active Expired - Fee Related
2004
- 2004-06-16 HK HK04104352A patent/HK1061231A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL156097A0 (en)	2003-12-23
SK6532003A3 (en)	2003-12-02
TWI254039B (en)	2006-05-01
CN1290825C (zh)	2006-12-20
CZ301631B6 (cs)	2010-05-05
HUP0303317A3 (en)	2010-04-28
IL156097A (en)	2010-11-30
PT1339675E (pt)	2005-04-29
HK1061231A1 (en)	2004-09-10
DE50105386D1 (de)	2005-03-24
NO20032438L (no)	2003-07-09
US20030225099A1 (en)	2003-12-04
HRP20030436B1 (en)	2006-04-30
HUP0303317A2 (hu)	2004-01-28
RS37603A (en)	2006-12-15
KR100968056B1 (ko)	2010-07-08
AU2002227931B2 (en)	2006-07-13
MXPA03004386A (es)	2003-09-04
JP2004514707A (ja)	2004-05-20
KR20030062364A (ko)	2003-07-23
ATE289292T1 (de)	2005-03-15
US20030013719A1 (en)	2003-01-16
CA2430273A1 (en)	2002-06-06
BR0115769A (pt)	2004-01-13
RS50403B (sr)	2009-12-31
EE200300183A (et)	2003-06-16
ZA200303893B (en)	2004-04-15
EP1339675A1 (de)	2003-09-03
HRP20030436A2 (en)	2005-04-30
NZ526177A (en)	2004-11-26
NO20032438D0 (no)	2003-05-28
CA2430273C (en)	2010-02-09
EE05240B1 (et)	2009-12-15
PL362700A1 (en)	2004-11-02
NO328599B1 (no)	2010-03-29
RU2278858C2 (ru)	2006-06-27
US6605625B2 (en)	2003-08-12
AR031430A1 (es)	2003-09-24
US6924392B2 (en)	2005-08-02
CN1494527A (zh)	2004-05-05
ES2236341T3 (es)	2005-07-16
AU2793102A (en)	2002-06-11
EP1339675B1 (de)	2005-02-16
SK286708B6 (sk)	2009-03-05
WO2002044137A1 (de)	2002-06-06
PL206245B1 (pl)	2010-07-30
JP4051283B2 (ja)	2008-02-20
DE10059418A1 (de)	2002-06-20

Publication	Publication Date	Title
CZ20031502A3 (cs)	2003-08-13	Ortho- a meta-substituované bisarylové sloučeniny a farmaceutické prostředky, které je obsahují
NO20071303L (no)	2001-07-27	Farmasoytiske preparater
NO20020304L (no)	2002-03-21	Konserverte farmasoytiske preparater
IL152659A0 (en)	2003-06-24	Pharmaceutical composition
HK1075889A1 (en)	2005-12-30	Pharmaceutical composition
HUP0204555A3 (en)	2004-06-28	Pharmaceutical composition
GB0006133D0 (en)	2000-05-03	Novel pharmaceutical
ATE332132T1 (de)	2006-07-15	Verbesserte arzneizubereitungen enthaltend ritonavir
GB0025473D0 (en)	2000-11-29	Pharmaceutical combinations
HUP0300334A3 (en)	2005-04-28	Pharmaceutical preparations and their manufacture
IL154238A0 (en)	2003-09-17	Pharmaceutical composition
GB0019228D0 (en)	2000-09-27	Novel pharmaceutical
GB0021865D0 (en)	2000-10-18	Novel pharmaceutical
GB0005382D0 (en)	2000-04-26	Pharmaceutical composition
GB0014006D0 (en)	2000-08-02	Novel pharmaceutical
GB0019224D0 (en)	2000-09-27	Novel pharmaceutical
GB0019226D0 (en)	2000-09-27	Novel pharmaceutical
GB0021487D0 (en)	2000-10-18	Pharmaceutical
GB0014005D0 (en)	2000-08-02	Novel pharmaceutical
ZA200205556B (en)	2003-07-11	Pharmaceutical compositions and their preparation.
GB0019223D0 (en)	2000-09-27	Novel pharmaceutical
GB0021785D0 (en)	2000-10-18	Novel Pharmaceutical
GB0029537D0 (en)	2001-01-17	Dual therapeusis and dual potencies in pharmaceutical preparations
GB0002691D0 (en)	2000-03-29	Pharmaceutical composition
GB0101094D0 (en)	2001-02-28	Pharmaceutical composition

Legal Events

Date	Code	Title	Description
2012-06-20	MM4A	Patent lapsed due to non-payment of fee	Effective date: 20111117